Bodal Chemicals Q1 FY27: Revenue Surges 56%, But Margins Stay Under Pressure
Bodal Chemicals Ltd
BODALCHEM
Ask Iris
Bodal Chemicals opened FY27 with a sharp jump in scale. In Q1 FY27, consolidated revenue rose to Rs 715.2 crore, up 56% year on year. EBITDA increased to Rs 75.1 crore, up 45%, while PAT more than tripled to Rs 30.4 crore. The quarter reflected a mix of stronger demand, higher realisations, and a clear pass-through of raw material inflation. But it also showed that margins remain sensitive to input costs.
A key driver was the company’s crude-linked raw material basket. Management noted that rising crude pushed up raw material prices, but improved demand allowed Bodal to pass on the impact. The company also highlighted that its integrated model and the cascading effect across the value chain improved realisations and supported the topline.
A quarter led by dyes and intermediates
Bodal’s revenue base remains anchored in dyes and dye intermediates. In Q1 FY27, dye intermediates revenue rose 44% year on year to Rs 216.6 crore, supported by both realisation and volume gains. Dyestuff revenue increased 23% to Rs 149.0 crore, and management said better realisations helped absorb raw material pressure. Basic chemicals revenue nearly doubled to Rs 83.9 crore, largely due to higher sulphur prices flowing through to selling prices.
Chlor Alkali was steadier, with revenue of Rs 87.0 crore, up 3% year on year. Volumes were mixed on a standalone basis. Dye intermediates volumes rose to 8,126 MT from 6,892 MT, while caustic soda production fell to 18,763 MT from 20,557 MT.
The company also pointed to the early contribution from its Saykha benzene downstream products division, which started adding to topline during the quarter. Management expects gradual growth from this division, with meaningful quarter-on-quarter contribution.
Mix shifts and exports remain meaningful
The mix shifted slightly in Q1 FY27. Based on the presentation’s revenue split, dyestuff accounted for 31% of product revenue, dye intermediates 21%, basic chemicals 23%, chlor alkali 13%, and others 12%. In Q1 FY26, dye intermediates formed a larger 27% share while basic chemicals were at 19%.
Geographically, the company continued to be export-oriented, with Q1 FY27 showing 81% export and 19% domestic in the chart provided for the quarter’s product sales excluding other non-operating income. Over a longer horizon, the presentation shows exports as 21% of FY26 sales on a standalone basis, down from 25% in FY25. The company states it has presence in 30 plus countries across North America, Europe, South America, India, and the rest of Asia.
Subsidiaries: Turkey improves, China weakens
Subsidiary performance was uneven. Sen-er Boya, the Turkish subsidiary, reported a stronger quarter with revenue rising 41% to Rs 6.5 crore and PAT at Rs 2.15 crore compared with a loss in Q1 FY26. BCTPL, the domestic trading unit, also grew from Rs 2.46 crore to Rs 6.52 crore in sales.
The China trading subsidiary fell sharply, with Q1 FY27 sales of Rs 1.09 crore versus Rs 7.95 crore in Q1 FY26. The Indonesia subsidiary also declined to Rs 1.44 crore in sales and reported a loss.
On the consolidated P&L, the company recorded a Rs 1.31 crore loss arising from a subsidiary operating in hyperinflationary economies, similar in magnitude to the prior year quarter.
Scale, integration, and compliance remain core pillars
Bodal positions itself as an integrated chemical player spanning basic chemicals, dye intermediates, dyestuffs, and chlor alkali. The company notes that about 40% of basic chemicals output is captively consumed by dye intermediates and about 40% of dye intermediates output is consumed by dyestuffs. This integration is presented as a structural cost advantage that can soften commodity cycles.
The company reports around 470,000 MTPA of total capacity across segments, including 217,600 MTPA in basic chemicals, 38,400 MTPA in dye intermediates, 99,000 MTPA in caustic soda, and 63,000 MTPA in benzene downstream products. It operates eight manufacturing facilities across Gujarat, Punjab, and Uttar Pradesh, supported by in-house R and D labs in Vadodara.
Compliance is a repeated theme in the deck. Multiple sites are described as zero discharge, supported by effluent treatment plants, multiple effect evaporators, and other pollution control systems. The company also highlights captive power assets including a 5 MW co-generation plant and a 1.73 MW waste heat based unit.
What to track from here
The Q1 FY27 jump in revenue and profit shows operating leverage kicking in as volumes and realisations improve. At the same time, EBITDA margin declined year on year, indicating that input cost inflation continues to test profitability even with pass-through.
Two operating levers stand out for investors to track. First, the ramp-up trajectory and commercial contribution of the Saykha benzene downstream portfolio, which management expects to grow quarter on quarter. Second, stability and recovery in overseas trading subsidiaries, especially China and Indonesia, which were subdued in the quarter.
Overall, the presentation reflects a company leaning on integration, scale, and compliance to grow through cycles, with near-term focus on maintaining revenue and margins through volume improvement and raw material cost pass-through.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
